Egocort

Egocort

hydrocortisone

Manufacturer:

Ego

Distributor:

Zuellig Pharma
Full Prescribing Info
Contents
Hydrocortisone.
Description
Egocort contains hydrocortisone dissolved in an occlusive cream base.
Action
Anti-inflammatory topical corticosteroid.
Indications/Uses
For the symptomatic relief of inflammation associated with steroid responsive conditions such as dermatitis, eczema and psoriasis.
Dosage/Direction for Use
Apply a thin film 1 to 2 times daily or as directed by the physician to affected areas.
Adjunct Therapy: As soap may irritate the skin, cleanse with a soap alternative eg, Pinetarsol gel or QV wash. As prolonged use is not advisable, use alternatives eg, Egoderm ointment (for soothing effect), or Egoderm cream (for emollient effect if the skin is dry) for continued control if long-term therapy is required. To help prevent recurrence, use QV cream.
Contraindications
Vaccinia, chickenpox, herpes and other viral infections, tuberculosis of the skin and syphilitic skin disorders. Do not use hydrocortisone cream on the face, the anal or genital region, or on broken skin.
Special Precautions
Systemic effects are less likely to occur with hydrocortisone than with fluorinated steroid, however prolonged treatment or extensive areas in infants and young children should be avoided.
If any reaction should occur due to an allergy to a constituent, application should be discontinued. Should any fungal or bacterial infection be present, this must be controlled before using hydrocortisone.
Prolonged treatment with steroids, especially over large areas or if occlusive dressings are used, may cause excessive systemic absorption.
To prevent a rebound effect, the skin should be gradually weaned to a nonsteroid anti-inflammatory preparation.
Avoid large amounts, occlusion and prolonged treatment.
Use in Pregnancy & Lactation: Prolonged use should be avoided. Attempt to heal the condition with a nonsteroid cream.
Consult a doctor if pregnant or breastfeeding.
Use in Children: Do not use on children under 2 years except under medical supervision.
Infants: Use in infants should be avoided. Long-term therapy (>4 weeks) should be avoided and a nonsteroid cream used.
Use In Pregnancy & Lactation
Prolonged use should be avoided. Attempt to heal the condition with a nonsteroid cream.
Consult a doctor if pregnant or breastfeeding.
MIMS Class
Topical Corticosteroids
ATC Classification
D07AA02 - hydrocortisone ; Belongs to the class of weak (group I) corticosteroids. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Egocort cream 1 %
Packing/Price
15 g x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in